There was no significant difference in plasma ACE2 comparing patients with or without pre-existing lung disease, diabetes, or immunosuppressive conditions (P = 0.953, P = 0.291, and P = 0.237, respectively) (Fig 4). This evidence concerns the gene ACE2 and diabetes mellitus.